Abstract
Paracorporeal continuous-flow ventricular assist devices designed for short-term support can also potentially provide long-term circulatory support as bridges to transplantation in children. We describe the long-term use of the CentriMag biventricular assist device with multiple pump changes in a 9-year-old boy with idiopathic-dilated cardiomyopathy. The initially implanted Berlin Heart EXCOR pumps were replaced by CentriMag due to thromboembolic complications. The CentriMag pumps were exchanged 15 times due to clot and fibrin formation or when the pumps reached their expiration dates. Connecting CentriMag to Berlin Heart EXCOR cannulae effectively served as an alternative long-term hybrid bridge to transplantation for 235 days. The patient successfully underwent a transplant after 284 days. Judicious pump monitoring and timely pump exchanges can potentially overcome device-related complications and extend the duration on support.
Similar content being viewed by others
References
Conway J, Al-Aklabi M, Granoski D, Islam S, Ryerson L, Anand V, et al. Supporting pediatric patients with short-term continuous-flow devices. J Heart Lung Transplant. 2016;35:603–9.
Morales DLS, Rossano JW, VanderPluym C, Lorts A, Cantor R, St Louis JD, et al. Third annual pediatric interagency registry for mechanical circulatory support (Pedimacs) report: preimplant characteristics and outcomes. Ann Thorac Surg. 2019;107:993–1004.
Bhatia I, Ho KC, Rocha BA, Yam N, Lun KS, Yung TC, et al. Pediatric ventricular assist device therapy for advanced heart failure-Hong Kong experience. J Artif Organs. 2019;2019:1–9.
Lorts A, Eghtesady P, Mehegan M, Adachi I, Villa C, Davies R, et al. Outcomes of children supported with devices labeled as "temporary" or short term: a report from the pediatric interagency registry for mechanical circulatory support. J Heart Lung Transplant. 2018;37:54–60.
Griffith KE, Jenkins E, Stulak J, Paugh T, Pagani FD. Long-term use of the CentriMag(R) ventricular assist system as a right ventricular assist device: a case report. Perfusion. 2012;27:65–70.
Chenhsu RY, Chiang SC, Chou MH, Lin MF. Long-term treatment with warfarin in Chinese population. Ann Pharmacother. 2000;34:1395–401.
Gan GG, Teh A, Goh KY, Chong HT, Pang KW. Racial background is a determinant factor in the maintenance dosage of warfarin. Int J Hematol. 2003;78:84–6.
Yu HC, Chan TY, Critchley JA, Woo KS. Factors determining the maintenance dose of warfarin in Chinese patients. QJM. 1996;89:127–35.
You JH, Chan FW, Wong RS, Cheng G. Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation? Br J Clin Pharmacol. 2005;59:582–7.
Jordan LC, Ichord RN, Reinhartz O, Humpl T, Pruthi S, Tjossem C, et al. Neurological complications and outcomes in the Berlin Heart EXCOR(R) pediatric investigational device exemption trial. J Am Heart Assoc. 2015;4:e001429.
John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932–9.
Maat AP, van Thiel RJ, Dalinghaus M, Bogers AJ. Connecting the Centrimag Levitronix pump to Berlin Heart Excor cannulae; a new approach to bridge to bridge. J Heart Lung Transplant. 2008;27:112–5.
Shuhaiber JH, Jenkins D, Berman M, Parameshwar J, Dhital K, Tsui S, et al. The Papworth experience with the Levitronix CentriMag ventricular assist device. J Heart Lung Transplant. 2008;27:158–64.
Haj-Yahia S, Birks EJ, Amrani M, Petrou M, Bahrami T, Dreyfus G, et al. Bridging patients after salvage from bridge to decision directly to transplant by means of prolonged support with the CentriMag short-term centrifugal pump. J Thorac Cardiovasc Surg. 2009;138:227–30.
Mohite PN, Zych B, Popov AF, Sabashnikov A, Saez DG, Patil NP, et al. CentriMag short-term ventricular assist as a bridge to solution in patients with advanced heart failure: use beyond 30 days. Eur J Cardiothorac Surg. 2013;44:e310–e315315.
Cevasco MR, Li B, Han J, Chiuzan C, Mauro CM, Kurlansky P, et al. Adverse event profile associated with prolonged use of CentriMag ventricular assist device for refractory cardiogenic shock. Asaio J. 2019;65:806–11.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no potential conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bhatia, I., Rocha, B.A., Yam, N. et al. Long term CentriMag biventricular support using hybrid cannulation as a bridge to transplant in a pediatric patient. J Artif Organs 23, 374–377 (2020). https://doi.org/10.1007/s10047-020-01177-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-020-01177-w